| 영문 | denture | 한글 | 틀니, 의치 |
|---|---|---|---|
| 설명 | 자연치아와 그와 연관된 조직이 결손되었을 때, 인공적으로 대치하는 보철물. 넓은 의미로는 인공치를 갖는 보철물을 뜻하는데, 주로 국부의치(partial denture)와 총의치(complete denture)를 포함하여 사용한다. 기록에 따르면, BC 500~400년경 이미 현재의 의치와 방법상 큰 차가 없는 것이 있었다고 한다. 즉, 고대의 의치는 금속선이나 띠고리로 상아를 비롯하여 소나 하마의 치아를 깍은 것을 잇거나 납땜질을 한 모양인데, 현재의 국부의치나 가공의치(bridge)등의 방법과 유사하다고 한다. 총의치는 17~18세기경, 특히 근세 치과학의 아버지라고 하는 프랑스의 P. 포샤르(1678~1761)는 현대의 것에 가까운 총의치를 처음으로 고안하였다. 현재 사용되고 있는 의치의 종류는 다음과 같다. ① 가공의치 : 하나 또는 둘 이상의 자연치아가 결손되어 있을 때 결손된 부분에 가공치를 대입하는 데, 가공치와 인접한 자연치아에는 지대치로 하여금 관을 씌워 금관과 가공치가 연결되어 구강내에 영구 정착되는 보철물이다. 그 형태와 기능, 제작법과 적응 등은 다양하다. ② 국부의치 : 하나 또는 그 이상의 자연치아가 결손되었을 때, 즉 치아 자체가 결손된 상태는 아니며 치아와 연관된 지지조직이 결손되었을 때 지탱해 주는 치과보철물로, 가철식 또는 고정식이 모두 포함된다. 부분저인 치아상실이나 조직의 결손을 인공적으로 대치하는 보철물이다. ③ 총의치 : 자연치아가 하나도 없는 환자에게 인공적인 방법과 수단으로 여러 가지 재료를 사용하여 제작하는 의치를 말한다. 실제에 있어서 치과보철의 최종적인 보철물이라 볼 수 있다. 환자는 총의치를 장착함으로써 음식물을 씹거나 발음기능을 발휘하고, 외관상 자연스럽고, 연조직에 해가 없어야 한다. |
||
| 영문 | neonatal intensive care center | 한글 | 신생아 집중치료실 |
|---|---|---|---|
| 설명 | 미숙아나 가사 상태의 출산아를 집중적으로 보살피고 치료하는 기관. |
||
| 영문 | intensive care unit | 한글 | 중환자실 |
|---|---|---|---|
| 설명 | 병세나 상처 따위의 정도가 매우 심한 사람을 치료하고 돌볼 수 있도록 마련한 방. 호흡-순환-대사 등 정신적 급성기능상실의 환자를 취급하며 강력하고도 집중적인 진료를 하는 부분이다. 위독한 환자에 대하여는 24시간 체제로 대응한다. 충분히 훈련을 받은 의료진이 배치되며 기능적으로 설비가 갖추어져 있다. 심근경색증-호흡기능상실-콩팥기능상실-소아-신경외과계 등 특정환자를 대상으로 한다. |
||
| Dent, dent | dentistry, dentist, dental, dentition |
|---|---|
| FDP(s) | 1) Fibrinolytic split Products(= FSP) 2) Fibrinogen Degradation Products |
| FSP | familial spastic paraplegia; fibrin split products; fibrinogen split products; fine suspended partic... |
| DENT | Dental Exposure Normalization Technique |
| AADP | American Academy of Denture Prosthetics; amyloid A-degrading protease |
| FPD | Fixed-partial-denture |
|---|---|
| RPD | Removable partial denture |
| AGE | Advanced Glycation End Products |
| AGE | Advanced Glycosylated End-products |
| CPMP | Committee for Proprietary Medicinal Products |
dentagra
| dent | 1. <prefix> Relating to the teeth or dentition, dental. See: odonto-. Origin: L. Dens, tooth 2. A slight depression, or small notch or hollow, made by a blow or by pressure; an indentation. "A blow that would have made a dent in a pound of butter." (De Quincey) Origin: A variant of Dint. Source: Websters Dictionary (21 Jun 2000) |
|---|---|
| biological products | Complex pharmaceutical substances, preparations, or agents of organic origin, usually obtained by biological methods or assay, that depend for their action on the processes affecting immunity. They are used especially in diagnosis and treatment of disease (as vaccines or pollen extracts). Biological products are differentiated from biological factors in that the latter are compounds with biological or physiological activity made by living organisms. (12 Dec 1998) |
| blood products | Biopharmaceutical products purified from human blood, such as the blood clotting factor VIII used to treat haemophiliacs. (Recombinant factor VIII is also on the market.) The term also refers to biopharmaceuticals that act on blood or the cells that make blood. These products are often produced by the cells themselves, but in such tiny amounts that extracting them from blood is impractical, and so they are genetically engineered. (14 Nov 1997) |
| gene products, env | Retroviral proteins, often glycosylated, coded by the envelope (env) gene. They are usually synthesised as protein precursors (polyproteins) and later cleaved into the final products by a viral protease. (12 Dec 1998) |
| gene products, gag | Proteins coded by the retroviral gag gene. The products are usually synthesised as protein precursors or polyproteins, which are then cleaved by viral proteases to yield the final products. Many of the final products are associated with the nucleoprotein core of the virion. Gag is short for group-specific antigen. (12 Dec 1998) |
| gene products, nef | Products of the HIV nef gene (formerly 3'-orf gene). The products trans-suppress viral replication and function as negative regulators of transcription. Nef stands for negative factor. (12 Dec 1998) |
| gene products, pol | Retroviral proteins coded by the pol gene. Often synthesised as a gag-pol fusion protein (fusion proteins, gag-pol) and later cleaved into final products that include reverse transcriptase, endonuclease/integrase, and viral protease. Pol is short for polymerase, the enzyme class of reverse transcriptase. (12 Dec 1998) |
| gene products, rev | Trans-acting nuclear proteins whose functional expression are required for HIV viral replication. Specifically, the rev gene products are required for processing and translation of the HIV gag and env mRNAs, and thus rev regulates the expression of the viral structural proteins. Rev can also regulate viral regulatory proteins. A cis-acting antirepression sequence (car) in env, also known as the rev-responsive element (rre), is responsive to the rev gene product. Rev is short for regulator of virion. (12 Dec 1998) |
| gene products, rex | Post-transcriptional regulatory proteins required for the accumulation of mRNAs that encode the gag and env gene products in HTLV-I and HTLV-II. The rex (regulator x; x is undefined) products act by binding to elements in the ltr. (12 Dec 1998) |
| gene products, tat | Trans-acting transcription factors. Nuclear proteins whose expression is required for HIV viral replication. The tat protein stimulates HIV-ltr-driven RNA synthesis for both viral regulatory and viral structural proteins. Tat stands for trans-activation of transcription. (12 Dec 1998) |
| gene products, tax | Transcriptional trans-acting proteins of the promoter elements found in the long-terminal repeats (ltr) of HTLV-I and HTLV-II. The tax (trans-activator x; x is undefined) proteins act by binding to enhancer elements in the ltr. (12 Dec 1998) |
| gene products, vif | A 23 kD regulatory protein important for virion infectivity in HIV. The protein is found in the cytoplasm of HIV-infected cells and is not absolutely required for virion formation. (12 Dec 1998) |
| gene products, vpr | Trans-acting proteins which accelerate virus replication in HIV. The vpr proteins act in trans to increase the levels of HIV specified proteins. Vpr is short for viral protein r, where r is undefined. (12 Dec 1998) |
| gene products, vpu | Non-glycosylated, membrane-associated, 16 kD proteins which are expressed in large amounts in cells infected with HIV-1. The proteins are required for efficient virion maturation and release. They are not present in HIV-2 nor in siv. Vpu is short for viral protein u, with u undefined. (12 Dec 1998) |
| meat products | Articles of food which are derived by a process of manufacture from any portion of carcasses of any animal used for food (e.g., head cheese, sausage, scrapple). (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|